Structure Therapeutics Inc. (GPCR)
Structure Therapeutics Inc. (GPCR) Insider Trading
Directors, officers and holders of more than 10% of GPCR report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 135 transactions on file: 0 with code P, 16 with code S and 34 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | S Sale | 4,008 | $36.15 | $144,873 |
| Sep 21, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | C Conversion | 4,008 | Not measured | Not measured |
| Sep 21, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | C Conversion | 12,024 | Not measured | Not measured |
| Sep 18, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | F Tax Payment | 10,626 | $11.67 | $124,005 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 17,817 | Not measured | Not measured |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 17,817 | Not measured | Not measured |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 17,817 | $0.3400 | $6,058 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 5,939 | Not measured | Not measured |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 1,300 | $45.86 | $59,623 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 4,539 | $47.20 | $214,254 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 100 | $47.83 | $4,783 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 400 | $55.05 | $22,020 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 3,020 | $53.13 | $160,462 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 519 | $54.20 | $28,128 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 11,817 | Not measured | Not measured |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 3,939 | Not measured | Not measured |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 11,817 | $0.3400 | $4,018 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 11,817 | Not measured | Not measured |
| Aug 6, 2026 | Berrios John Joseph | Chief Commercial Officer | A Award | 140,766 | Not measured | Not measured |
| Aug 6, 2026 | Berrios John Joseph | Chief Commercial Officer | A Award | 174,612 | Not measured | Not measured |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 11,817 | Not measured | Not measured |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 839 | $50.03 | $41,974 |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 11,817 | $0.3400 | $4,018 |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 11,817 | Not measured | Not measured |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 3,939 | Not measured | Not measured |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 3,100 | $49.29 | $152,786 |
| Jul 22, 2026 | FMR LLC | 10% Owner | S Sale | 1,367 | $50.07 | $68,446 |
| Jul 22, 2026 | FMR LLC | 10% Owner | S Sale | 16,085 | $50.07 | $805,376 |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 6,278 | $50.80 | $318,895 |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 1,600 | $51.71 | $82,734 |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 7,878 | Not measured | Not measured |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 23,634 | Not measured | Not measured |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 23,634 | Not measured | Not measured |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 23,634 | $0.3400 | $8,036 |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 7,878 | Not measured | Not measured |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 23,634 | Not measured | Not measured |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | S Sale | 7,878 | $49.08 | $386,646 |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | C Conversion | 23,634 | Not measured | Not measured |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | M Exercise | 23,634 | $0.3400 | $8,036 |
| Jun 17, 2026 | DOBMEIER ERIC | Director | A Award | 39,453 | Not measured | Not measured |
| Jun 17, 2026 | LOVE TED W | Director | A Award | 39,453 | Not measured | Not measured |
| Jun 17, 2026 | Russell Angus C. | Director | A Award | 39,453 | Not measured | Not measured |
| Jun 17, 2026 | Waldstreicher Joanne | Director | A Award | 39,453 | Not measured | Not measured |
| Jun 17, 2026 | TETLOW SHARON | Director | A Award | 39,453 | Not measured | Not measured |
| Jun 17, 2026 | WELCH DANIEL G | Director | A Award | 39,453 | Not measured | Not measured |
| Apr 15, 2026 | Lang Matthew | COO & GC | A Award | 223,776 | Not measured | Not measured |
| Apr 15, 2026 | Lang Matthew | COO & GC | A Award | 184,614 | Not measured | Not measured |
| Apr 14, 2026 | FMR LLC | 10% Owner | S Sale | 1,367 | $55.07 | $75,281 |
| Apr 14, 2026 | FMR LLC | 10% Owner | S Sale | 16,085 | $55.07 | $885,801 |
| Mar 19, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | A Award | 93,984 | Not measured | Not measured |
The full Form 4 history is on the GPCR company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.